[FULC] QoQ Quarter Result on 31-Mar-2024 [#Q4]

Stock
[FULC] Fulcrum Therapeutics, Inc.
Announcement Date
13-May-2024
Financial Year
2023
Quarter
31-Mar-2024 [#Q4]
Profit Trend
QoQ- -8.54%
YoY- -24.29%
Quarter Report
FULC's Result
FULC's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 80,000 0 871 759 880 295 685 2296.21%
PBT 55,409 -26,870 -24,756 -24,017 -23,783 -24,779 -26,135 -
Tax 0 435 3,161 409 525 -3,161 -2,505 -
NP 55,409 -26,870 -24,756 -24,017 -23,783 -21,618 -23,630 -
Tax Rate 0.00% - - - - - - -
Total Cost 24,591 26,870 25,627 24,776 24,663 21,913 24,315 0.75%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 69.26 0.00 -2,842.25 -3,164.30 -2,702.61 -7,328.14 -3,449.64 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS 0.89 -0.43 -0.40 -0.39 -0.38 -0.36 -0.45 -
EPS Diluted 0.87 -0.43 -0.40 -0.39 -0.38 -0.36 -0.45 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.